Page last updated: 2024-10-19

niacinamide and Leukemia, Megakaryocytic

niacinamide has been researched along with Leukemia, Megakaryocytic in 1 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
" A novel nicotinamide, AMG 706, was identified as a potent, orally bioavailable inhibitor of the VEGFR1/Flt1, VEGFR2/kinase domain receptor/Flk-1, VEGFR3/Flt4, platelet-derived growth factor receptor, and Kit receptors in preclinical models."1.33AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. ( Alva, G; Bready, J; Cattley, R; Chen, D; Coxon, A; DeMelfi, T; Diaz, Z; Estrada, J; Gan, Y; Kaufman, S; Kendall, R; Kumar, G; Meyer, J; Montestruque, S; Neervannan, S; Patel, V; Polverino, A; Radinsky, R; Starnes, C; Talvenheimo, J; Tasker, A; Wang, L, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polverino, A1
Coxon, A1
Starnes, C1
Diaz, Z1
DeMelfi, T1
Wang, L1
Bready, J1
Estrada, J1
Cattley, R1
Kaufman, S1
Chen, D1
Gan, Y1
Kumar, G1
Meyer, J1
Neervannan, S1
Alva, G1
Talvenheimo, J1
Montestruque, S1
Tasker, A1
Patel, V1
Radinsky, R1
Kendall, R1

Other Studies

1 other study available for niacinamide and Leukemia, Megakaryocytic

ArticleYear
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
    Cancer research, 2006, Sep-01, Volume: 66, Issue:17

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Endothelium

2006